Funder: Breakthrough T1D
Due Dates: Rolling (inquiries accepted year-round)
Funding Amounts: No explicit maximum; typically up to $900,000–$3,000,000 over 2–3 years (varies by program/RFA, requires company matching funds, and subject to negotiation).
Summary: Supports for-profit organizations in advancing research and development of innovative, commercially promising therapies for type 1 diabetes that align with Breakthrough T1D's strategic priorities.
Key Information: Indirect costs are not permitted; company matching funds are required; applicants must contact Breakthrough T1D before applying.